In vivo reprogramming and epigenetic rejuvenation of adult cardiomyocytes ameliorate heart failure in mice

Partial cell reprogramming has been demonstrated in certain mouse tissues by in situ overexpression of Oct3/4, Klf4, Sox2 and cMyc (OKSM) transcription factors, and can induce rejuvenation and/or augment regeneration. Reprogramming of adult cardiomyocytes has been elusive until recently, but its success could help overcome the lack of endogenous regenerative capacity of the mammalian myocardium. Here, we generated cardiomyocyte-specific, doxycycline-inducible, reprogrammable mice and demonstrated that sustained OKSM induction reprograms cardiomyocytes fully into teratoma-forming pluripotent cells. However, we also showed that cyclic OKSM upregulation induces significant decrease of epigenetic age in the cardiomyocytes without de-differentiation or reacquisition of pluripotency. In mice with progressive heart failure, cardiomyocyte epigenetic rejuvenation correlated with stabilization of systolic heart function. These findings confirm that OKSM can reprogram adult mouse cardiomyocytes to different states depending on the duration of their expression, and provide further evidence that partially reprogrammed cardiomyocytes may contribute to ameliorate cardiac disease.

[1]  F. Casas,et al.  A single short reprogramming early in life initiates and propagates an epigenetically related mechanism improving fitness and promoting an increased healthy lifespan , 2022, Aging cell.

[2]  C. Shao,et al.  In vivo partial cellular reprogramming enhances liver plasticity and regeneration , 2022, Cell reports.

[3]  S. Horvath,et al.  Genetic loci and metabolic states associated with murine epigenetic aging , 2022, bioRxiv.

[4]  S. Horvath,et al.  In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice , 2022, Nature Aging.

[5]  M. Fraga,et al.  Multi‐omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming , 2022, bioRxiv.

[6]  H. Schöler,et al.  Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice , 2021, Science.

[7]  J. I. Izpisúa Belmonte,et al.  In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche , 2021, Nature Communications.

[8]  G. Cossu,et al.  Transient reprogramming of postnatal cardiomyocytes to a dedifferentiated state , 2021, PloS one.

[9]  Robert W. Williams,et al.  Universal DNA Methylation Age Across Mammalian Tissues , 2021, bioRxiv.

[10]  Soo Bin Kwon,et al.  A mammalian methylation array for profiling methylation levels at conserved sequences , 2021, Nature Communications.

[11]  Margarita V. Meer,et al.  Reprogramming to recover youthful epigenetic information and restore vision , 2020, Nature.

[12]  E. Cartwright,et al.  Adenoviral Mediated Delivery of OSKM Factors Induces Partial Reprogramming of Mouse Cardiac Cells In Vivo , 2020 .

[13]  V. Gladyshev.  The Ground Zero of Organismal Life and Aging. , 2020, Trends in molecular medicine.

[14]  Lei S. Qi,et al.  Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells , 2020, Nature Communications.

[15]  Yohan Kim,et al.  Small-molecule-mediated reprogramming: a silver lining for regenerative medicine , 2020, Experimental & Molecular Medicine.

[16]  S. Horvath,et al.  DNA methylation aging clocks: challenges and recommendations , 2019, Genome Biology.

[17]  M. Salih,et al.  Cardiac-Specific Cre Induces Age-Dependent Dilated Cardiomyopathy (DCM) in Mice , 2019, Molecules.

[18]  G. Cossu,et al.  Non-viral, Tumor-free Induction of Transient Cell Reprogramming in Mouse Skeletal Muscle to Enhance Tissue Regeneration. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  H. Schöler,et al.  Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo , 2018, Stem cells.

[20]  D. Grimm,et al.  AAV vector-mediated in vivo reprogramming into pluripotency , 2018, Nature Communications.

[21]  Steve Horvath,et al.  DNA methylation-based biomarkers and the epigenetic clock theory of ageing , 2018, Nature Reviews Genetics.

[22]  Richard T. Lee,et al.  Cardiomyocyte Regeneration: A Consensus Statement. , 2017, Circulation.

[23]  G. Cossu,et al.  Transient transcription factor (OSKM) expression is key towards clinical translation of in vivo cell reprogramming , 2017, EMBO molecular medicine.

[24]  Peter Bankhead,et al.  QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.

[25]  C. R. Esteban,et al.  In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming , 2016, Cell.

[26]  R. Foo,et al.  A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes From the Adult Mouse Heart. , 2016, Circulation research.

[27]  Myungjae Song,et al.  In Situ Pluripotency Factor Expression Promotes Functional Recovery From Cerebral Ischemia , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  Phillip A. Richmond,et al.  Prolonged Cre expression driven by the α-myosin heavy chain promoter can be cardiotoxic. , 2015, Journal of molecular and cellular cardiology.

[29]  M. Neeman,et al.  ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation , 2015, Nature Cell Biology.

[30]  M. Giacca,et al.  In vivo activation of a conserved microRNA program induces mammalian heart regeneration. , 2014, Cell stem cell.

[31]  N. Humphreys,et al.  Generation of induced pluripotent stem cells from virus-free in vivo reprogramming of BALB/c mouse liver cells. , 2014, Biomaterials.

[32]  Kostas Kostarelos,et al.  In vivo cell reprogramming to pluripotency: exploring a novel tool for cell replenishment and tissue regeneration , 2014 .

[33]  Jose M Polo,et al.  Phases of reprogramming. , 2014, Stem cell research.

[34]  Mario J. Garcia,et al.  Cyclin A2 Induces Cardiac Regeneration After Myocardial Infarction Through Cytokinesis of Adult Cardiomyocytes , 2014, Science Translational Medicine.

[35]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[36]  M. Serrano,et al.  Reprogramming in vivo produces teratomas and iPS cells with totipotency features , 2013, Nature.

[37]  Kostas Kostarelos,et al.  In Vivo Cell Reprogramming towards Pluripotency by Virus-Free Overexpression of Defined Factors , 2013, PloS one.

[38]  P. Arlotta,et al.  Direct lineage reprogramming of post-mitotic callosal neurons into corticofugal neurons in vivo , 2013, Nature Cell Biology.

[39]  C. Lüscher,et al.  In vivo reprogramming of circuit connectivity in postmitotic neocortical neurons , 2013, Nature Neuroscience.

[40]  S. Ramaswamy,et al.  A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells , 2012, Cell.

[41]  K. Hochedlinger,et al.  Efficient Generation of iPS Cells from Skeletal Muscle Stem Cells , 2011, PloS one.

[42]  C. Lengner,et al.  Reprogramming of Postnatal Neurons into Induced Pluripotent Stem Cells by Defined Factors , 2011, Stem cells.

[43]  K. Hochedlinger,et al.  Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells , 2010, Nature Biotechnology.

[44]  K. Hochedlinger,et al.  Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells , 2009, Nature Genetics.

[45]  V. Beneš,et al.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.

[46]  J. Whitsett,et al.  Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction , 2005, Nucleic acids research.

[47]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[48]  E. Morkin.  Control of cardiac myosin heavy chain gene expression , 2000, Microscopy research and technique.

[49]  P. Douglas,et al.  Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy , 2000, Nature Medicine.

[50]  B. A. French,et al.  Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. , 1997, The Journal of clinical investigation.

[51]  R. Wesselschmidt.  The teratoma assay: an in vivo assessment of pluripotency. , 2011, Methods in molecular biology.

[52]  K. Hochedlinger,et al.  A reprogrammable mouse strain from gene-targeted embryonic stem cells , 2010, Nature Methods.